[go: up one dir, main page]

DE60331920D1 - Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren - Google Patents

Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren

Info

Publication number
DE60331920D1
DE60331920D1 DE60331920T DE60331920T DE60331920D1 DE 60331920 D1 DE60331920 D1 DE 60331920D1 DE 60331920 T DE60331920 T DE 60331920T DE 60331920 T DE60331920 T DE 60331920T DE 60331920 D1 DE60331920 D1 DE 60331920D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
capsules
oral pharmaceutical
vinorelbine
vinorelbin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331920T
Other languages
English (en)
Inventor
Joel Bougaret
Elie Leverd
Marie-Madeleine Bohn
Norbert Heintz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29715700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60331920(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0206886A external-priority patent/FR2840203B1/fr
Priority claimed from CA002388431A external-priority patent/CA2388431C/en
Priority claimed from US10/161,454 external-priority patent/US6890558B2/en
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Application granted granted Critical
Publication of DE60331920D1 publication Critical patent/DE60331920D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60331920T 2002-05-31 2003-05-28 Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren Expired - Lifetime DE60331920D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0206886A FR2840203B1 (fr) 2002-05-31 2002-05-31 Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement
CA002388431A CA2388431C (en) 2002-05-31 2002-05-31 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
US10/161,454 US6890558B2 (en) 2002-05-31 2002-05-31 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
PCT/US2003/016732 WO2003101383A2 (en) 2002-05-31 2003-05-28 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment

Publications (1)

Publication Number Publication Date
DE60331920D1 true DE60331920D1 (de) 2010-05-12

Family

ID=29715700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331920T Expired - Lifetime DE60331920D1 (de) 2002-05-31 2003-05-28 Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren

Country Status (14)

Country Link
EP (1) EP1530459B1 (de)
JP (2) JP4718170B2 (de)
CN (1) CN1287794C (de)
AT (1) ATE462419T1 (de)
AU (1) AU2003240808B2 (de)
BR (2) BRPI0307816B8 (de)
CY (1) CY1110184T1 (de)
DE (1) DE60331920D1 (de)
DK (1) DK1530459T3 (de)
ES (1) ES2343790T3 (de)
MX (1) MXPA04006054A (de)
PT (1) PT1530459E (de)
SI (1) SI1530459T1 (de)
WO (1) WO2003101383A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2880274B1 (fr) * 2004-12-30 2007-04-13 Pierre Fabre Medicament Sa Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication
WO2006069938A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
CN101134026B (zh) * 2006-08-31 2011-12-07 江苏豪森药业股份有限公司 长春瑞滨软胶囊及其制备方法和其应用
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
WO2009105937A1 (zh) * 2008-02-29 2009-09-03 江苏豪森药业股份有限公司 长春瑞滨软胶囊及其制备方法和其应用
CN108779129A (zh) 2016-03-09 2018-11-09 赛比亚斯药业股份公司 长春瑞滨单酒石酸盐及其药物用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623629A (en) * 1983-10-31 1986-11-18 Daniel Kerschensteiner Solid-phase immunoassay support and method of use thereof
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
DE19545043A1 (de) * 1995-12-02 1997-06-05 Scherer Gmbh R P Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung
AU773061B2 (en) * 1999-05-24 2004-05-13 Southern Research Institute Isophosphoramide mustard analogs and use thereof

Also Published As

Publication number Publication date
CN1638745A (zh) 2005-07-13
WO2003101383A2 (en) 2003-12-11
EP1530459B1 (de) 2010-03-31
EP1530459A2 (de) 2005-05-18
EP1530459A4 (de) 2007-08-22
CY1110184T1 (el) 2015-01-14
AU2003240808A1 (en) 2003-12-19
WO2003101383A3 (en) 2004-09-30
JP4718170B2 (ja) 2011-07-06
DK1530459T3 (da) 2010-07-19
SI1530459T1 (sl) 2010-08-31
JP2010280739A (ja) 2010-12-16
BR0307816A (pt) 2005-08-02
BR0307816C1 (pt) 2006-09-19
BRPI0307816F1 (pt) 2022-02-15
JP2006516111A (ja) 2006-06-22
PT1530459E (pt) 2010-05-20
BRPI0307816B8 (pt) 2021-05-25
CN1287794C (zh) 2006-12-06
BRPI0307816B1 (pt) 2018-03-06
HK1079421A1 (en) 2006-04-07
MXPA04006054A (es) 2004-09-27
JP5334937B2 (ja) 2013-11-06
AU2003240808B2 (en) 2008-05-08
ATE462419T1 (de) 2010-04-15
ES2343790T3 (es) 2010-08-10

Similar Documents

Publication Publication Date Title
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
ES2180646T3 (es) Formulaciones liquidas orales de alendronato.
EP3478283A1 (de) Verwendung von neurokinin-1-antagonisten zur behandlung verschiedener pruriginöser störungen
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
CA2434484A1 (en) Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances
EP2444072A3 (de) Nichtmukoadhäsive Filmdosierungsformen
RU2003116058A (ru) Композиции гидрокодона с контролируемым высвобождением
DE69532678D1 (de) Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende Arzneimittel
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
UY27533A1 (es) Composiciones farmacéuticas que contienen oxibutinina
CY1110184T1 (el) Φαρμακευτικη συνθεση για μαλακες καψουλες για χορηγηση απο το στομα η οποια περιεχει βινορελβινη και μεθοδος θεραπειας
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
EP1365749A4 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
NO20055880L (no) Memantin orale doseringsformer
HRP20050544A2 (en) Solid drug for oral use
CO5580741A2 (es) Composicion farmaceutica que comprende un agonista de receptor de 5ht1
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
HN2001000038A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina
ATE283036T1 (de) Pharmazeutische zusammensetzung mit gesteuerter freigabe enthaltend midodrin und/oder desglymidodrin
RU2008110933A (ru) Применение амброксола для лечения риновирусных инфекций
KR20060126555A (ko) 피부학적 연질 겔 조성물
WO2023150579A3 (en) Pharmaceutical formulations containing nalbuphine
CA2388431A1 (en) Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
RU2004119829A (ru) Пероральная фармацевтическая композиция для мягких капсул, содержащая винорелбин, и способ лечения
RU99118938A (ru) Способ лечения обострения хронического панкреатита

Legal Events

Date Code Title Description
8363 Opposition against the patent